Inhaled Corticosteroids for Treatment of Bronchopulmonary Dysplasia

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

July 27, 2001

Primary Completion Date

November 15, 2006

Study Completion Date

November 15, 2006

Conditions
Bronchopulmonary Dysplasia
Interventions
DRUG

Inhaled Beclomethasone Dipropionate Monohydrate

"Beclomethasone Dipropionate (HFA-BDP, QVAR\*) in the following doses will be evaluated:~1. 200 mcg bid~2. 400 mcg bid~3. 600 mcg bid~4. 800 mcg bid"

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Sunnybrook Health Sciences Centre

OTHER

collaborator

IWK Health Centre

OTHER

lead

Mount Sinai Hospital, Canada

OTHER